MRI Clinical Trials

71 recruitingLast updated: June 17, 2026

There are 71 actively recruiting mri clinical trials across 18 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 3, Phase 1. Top locations include Bethesda, Maryland, United States, Beijing, China, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


MRI Trials at a Glance

71 actively recruiting trials for mri are listed on ClinicalTrialsFinder across 6 cities in 18 countries. The largest study group is Not Applicable with 33 trials, with the heaviest enrollment activity in Bethesda, Beijing, and Beijing. Lead sponsors running mri studies include Chinese PLA General Hospital, Fondation Ophtalmologique Adolphe de Rothschild, and National Institute of Mental Health (NIMH).

Browse mri trials by phase

Treatments under study

About MRI Clinical Trials

Looking for clinical trials for MRI? There are currently 25 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new MRI trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about MRI clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 71 trials

Recruiting

Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)

MRIMultiple SclerosisNMO Spectrum Disorder+1 more
Beijing Tiantan Hospital1,000 enrolled1 locationNCT04106830
Recruiting

Top-Down Attentional Control of Visual-Processing

fMRIFocal Brain LesionFocal Lesions
National Institute of Mental Health (NIMH)300 enrolled1 locationNCT01087281
Recruiting

Brain Stimulation and Vision Testing

fMRIDorsal PathwayVentral Pathway
National Institute of Mental Health (NIMH)665 enrolled1 locationNCT01617408
Recruiting
Phase 2

18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer

Breast Cancer FemaleLobular Breast CarcinomaPET/MRI+2 more
Università Vita-Salute San Raffaele119 enrolled1 locationNCT05982496
Recruiting
Not Applicable

OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases

Liver MetastasesStereotactic Body Radiation TherapyMRI-guided Treatment
University of Wisconsin, Madison32 enrolled1 locationNCT04020276
Recruiting

Study of New Magnetic Resonance Imaging Methods of the Brain

HealthyHealthy VolunteerAdult+3 more
National Institute of Neurological Disorders and Stroke (NINDS)1,100 enrolled1 locationNCT00004577
Recruiting

Brain Connectivity Changes in Glioma Patients During Treatment

Glioma (Any Grade) in the BrainNeurocognitive FunctionGliomas, Malignant+1 more
Johannes Kepler University of Linz20 enrolled1 locationNCT07612917
Recruiting
Phase 4

Propofol-Only Versus Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging

DexmedetomidinePediatric SedationRecovery Time+3 more
Boston Children's Hospital105 enrolled1 locationNCT07369128
Recruiting
Not Applicable

Flumazenil for Benzodiazepine Reversal in Electroconvulsive Therapy

Autobiographical MemoryDepression - Major Depressive DisorderTreatment Outcome+6 more
Anders Jørgensen145 enrolled1 locationNCT07619092
Recruiting

A Longitudinal Investigation of the Endocrine and Neurobiologic Events Accompanying Puberty

fMRI
National Institute of Mental Health (NIMH)370 enrolled1 locationNCT01434368
Recruiting
Not Applicable

Application of a Dental-dedicated MRI in the Diagnosis of Temporomandibular Joint Disorders, Tissue Alterations Related to Third Molars, Periapical and Periodontal Inflammatory Diseases, and Implant Treatment Planning

Apical periodontitisperiodontal inflammationMRI+2 more
University of Aarhus470 enrolled1 locationNCT05439330
Recruiting
Not Applicable

Comparative Efficacy of Intra-articular vs. MRI-guided Extra-articular Dextrose Injections in Knee Osteoarthritis Management

MRIKnee OsteoarthritisRehabilitation+3 more
Shin Kong Wu Ho-Su Memorial Hospital60 enrolled1 locationNCT06755697
Recruiting
Not Applicable

Cross Modal Correlation of EEG and MRI Functional Connectivity: An Investigative Study

MRI, Functional MRI
Assaf-Harofeh Medical Center1,500 enrolled1 locationNCT07539506
Recruiting
Not Applicable

ETASCAN Project: ETAS Project 2

MRISleepCognition+3 more
University of Reading60 enrolled1 locationNCT07550140
Recruiting
Phase 3

A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Central Nervous System (CNS) Lesions

For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesions
Shanghai Shengdi Pharmaceutical Co., Ltd250 enrolled2 locationsNCT07275814
Recruiting
Not Applicable

Optimizing Liver MRI Using Breath-Holding With and Without Oxygen

MRIMRI Image Enhancement
University of California, San Francisco10 enrolled1 locationNCT07135401
Recruiting
Phase 3

A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-Central Nervous System) Lesions

For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Abnormal Vascular Lesions in Body Regions Excluding the Central Nervous System (CNS)
Shanghai Shengdi Pharmaceutical Co., Ltd306 enrolled2 locationsNCT07275723
Recruiting

NEWPROMRI-PATHWAY - A New Prostate Magnetic Resonance Imaging (MRI) Pathway

Prostate CancerMRI
University Hospitals of North Midlands NHS Trust1,600 enrolled1 locationNCT06672926
Recruiting
Phase 2Phase 3

Effects of Ketone Supplement and Alcohol on Brain Metabolism

MRIKetosisAlcohol Drinking
University of Pennsylvania60 enrolled1 locationNCT06815237
Recruiting
Not Applicable

New Care Pathway Using Automated Dynamic Laximetry

MRIAutomated Dynamic Laximetry (ADL)Care Pathway+1 more
University Hospital, Angers80 enrolled3 locationsNCT07028476